Company · CIK 0000920148 · SIC 8071 — Services-Medical Laboratories · NYSE
LABCORP HOLDINGS INC. · LH
Insider activity reported against this company. All insider holders · Files at: SQNM. On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 17, 2026 SForm 4 → | Aug 18, 8:10 am EDT | Kerrii B AndersonDirector | 3,000 | $318.02 | $954,060 | 6,563 | −31.4% | 10b5-1 |
| Aug 11, 2026 SForm 4 → | Aug 12, 2:31 pm EDT | Adam H SchechterPresident & CEO, Director | 4,669 | $320.37 | $1,495,808 | 102,565 | −4.35% | 10b5-1 |
| Aug 4, 2026 SForm 4 → | Aug 6, 8:26 am EDT | Amy B. SummyEVP, Chief Marketing Officer | 924 | $306.74 | $283,428 | 6,956 | −11.7% | |
| Aug 3, 2026 MForm 4 → | Aug 5, 11:17 am EDT | Peter J WilkinsonSVP, Chief Accounting Officer | 1,338 | $209.25 | $279,977 | 3,108 | — | |
| Aug 3, 2026 SForm 4 → | Aug 5, 11:17 am EDT | Peter J WilkinsonSVP, Chief Accounting Officer | 1,420 | $309.23 | $439,107 | 1,770 | −44.5% | |
| Jul 2, 2026 SForm 4 → | Jul 6, 9:37 am EDT | Kathryn W KyleEVP, Chief Legal Officer | 92 | $286.19 | $26,329 | 3,904 | −2.30% | 10b5-1 |
| Jul 2, 2026 SForm 4 → | Jul 6, 9:36 am EDT | Bryan T VaughnEVP and President, Diagnostics | 234 | $286.19 | $66,968 | 6,746 | −3.35% | 10b5-1 |
| Jul 1, 2026 FMForm 4 → | Jul 6, 9:37 am EDT | Kathryn W KyleEVP, Chief Legal Officer | 329 | $283.88 | $20,723 | 3,996 | — | 10b5-1 |
| Jul 1, 2026 FMForm 4 → | Jul 6, 9:36 am EDT | Bryan T VaughnEVP and President, Diagnostics | 420 | $283.88 | $26,401 | 6,980 | — | 10b5-1 |
| Jun 8, 2026 SForm 4 → | Jun 10, 9:01 am EDT | Kathryn W KyleEVP, Chief Legal Officer | 762 | $263.89 | $201,084 | 3,813 | −16.7% | 10b5-1 |
| Feb 13, 2019 SForm 4 → | Feb 14, 4:18 pm EST | R Sanders WilliamsDirector | 1,038 | $147.00 | $152,586 | 7,886 | −11.6% | plan? |
| Feb 12, 2019 SForm 4 → | Feb 14, 5:01 pm EST | Jean-Luc BelingardDirector | 3,700 | $146.06 | $540,407 | 33,079 | −10.1% | plan? |
| Feb 12, 2019 FMForm 4 → | Feb 14, 5:01 pm EST | Jean-Luc BelingardDirector | 4,842 | $66.67 | $253,599 | 34,013 | — | plan? |
| Feb 12, 2019 FMForm 4 → | Feb 14, 4:44 pm EST | David P KingPresident & CEO, Director | 5,084 | $146.59 | $230,293 | 246,281 | — | plan? |
| Feb 12, 2019 MForm 4 → | Feb 14, 4:37 pm EST | Peter M NeupertDirector | 1,038 | — | — | 8,769 | — | plan? |
| Feb 12, 2019 MForm 4 → | Feb 14, 4:33 pm EST | Dwight Gary GillilandDirector | 1,038 | — | — | 4,539 | — | plan? |
| Feb 12, 2019 MForm 4 → | Feb 14, 4:30 pm EST | Kerrii B AndersonDirector | 1,038 | — | — | 19,133 | — | plan? |
| Feb 12, 2019 MForm 4 → | Feb 14, 4:27 pm EST | Garheng KongDirector | 1,038 | — | — | 7,225 | — | plan? |
| Feb 12, 2019 MForm 4 → | Feb 14, 4:26 pm EST | Richelle P ParhamDirector | 1,038 | — | — | 3,861 | — | plan? |
| Feb 12, 2019 MForm 4 → | Feb 14, 4:25 pm EST | Robert E Mittelstaedt Jr.Director | 1,038 | — | — | 15,209 | — | plan? |
| Feb 12, 2019 MForm 4 → | Feb 14, 4:18 pm EST | R Sanders WilliamsDirector | 1,038 | — | — | 8,924 | — | plan? |
| Feb 12, 2019 FMForm 4 → | Feb 14, 4:13 pm EST | Edward T DodsonPrincipal Accounting Officer | 250 | $146.59 | $7,916 | 9,912 | — | plan? |
| Feb 12, 2019 FMForm 4 → | Feb 14, 4:10 pm EST | F Samuel Eberts IIIChief Legal Officer, Secretary | 297 | $146.59 | $9,382 | 28,823 | — | plan? |
| Feb 12, 2019 FMForm 4 → | Feb 14, 4:08 pm EST | John D RatliffCEO, Covance Drug Development | 2,117 | $146.59 | $95,870 | 15,601 | — | plan? |
| Feb 12, 2019 FMForm 4 → | Feb 14, 4:05 pm EST | Glenn A EisenbergChief Financial Officer, EVP | 1,012 | $146.59 | $34,009 | 20,235 | — | plan? |
| Feb 12, 2019 FMForm 4 → | Feb 14, 4:02 pm EST | Lance BerberianSVP, Chief Information Officer | 303 | $146.59 | $10,261 | 8,756 | — | plan? |
| Feb 12, 2019 FMForm 4 → | Feb 14, 3:59 pm EST | Brian J CaveneySVP, Chief Medical Officer | 315 | $146.59 | $12,020 | 151 | — | plan? |
| Feb 12, 2019 FMForm 4 → | Feb 14, 3:58 pm EST | Lisa J UthgenanntChief Human Resources Officer | 359 | $146.59 | $15,099 | 4,489 | — | plan? |
| Feb 11, 2019 FMForm 4 → | Feb 13, 12:22 pm EST | Lisa J UthgenanntChief Human Resources Officer | 844 | $144.29 | $34,630 | 4,336 | — | plan? |
| Feb 11, 2019 FMForm 4 → | Feb 13, 12:18 pm EST | Edward T DodsonPrincipal Accounting Officer | 574 | $144.29 | $17,892 | 9,770 | — | plan? |
| Feb 11, 2019 FMForm 4 → | Feb 13, 12:11 pm EST | David P KingPresident & CEO, Director | 10,524 | $144.29 | $429,984 | 244,339 | — | plan? |
| Feb 11, 2019 FMForm 4 → | Feb 13, 12:09 pm EST | F Samuel Eberts IIIChief Legal Officer, Secretary | 663 | $144.29 | $20,633 | 28,654 | — | plan? |
| Feb 11, 2019 FMForm 4 → | Feb 13, 12:05 pm EST | Glenn A EisenbergChief Financial Officer, EVP | 6,326 | $144.29 | $209,076 | 19,687 | — | plan? |
| Feb 11, 2019 FMForm 4 → | Feb 13, 12:00 pm EST | Lance BerberianSVP, Chief Information Officer | 4,534 | $144.29 | $149,629 | 8,593 | — | plan? |
| Feb 11, 2019 FMForm 4 → | Feb 13, 11:55 am EST | John D RatliffCEO, Covance Drug Development | 8,073 | $144.29 | $284,684 | 14,792 | — | plan? |
| Feb 7, 2019 FMForm 4 → | Feb 11, 7:59 pm EST | John D RatliffCEO, Covance Drug Development | 2,419 | $147.46 | $81,988 | 10,665 | — | plan? |
| Feb 7, 2019 FMForm 4 → | Feb 11, 7:56 pm EST | David P KingPresident & CEO, Director | 5,474 | $147.46 | $184,915 | 239,775 | — | plan? |
| Feb 7, 2019 FMForm 4 → | Feb 11, 7:53 pm EST | Glenn A EisenbergChief Financial Officer, EVP | 1,290 | $147.46 | $43,796 | 16,259 | — | plan? |
| Feb 7, 2019 FMForm 4 → | Feb 11, 7:51 pm EST | F Samuel Eberts IIIChief Legal Officer, Secretary | 379 | $147.46 | $12,092 | 28,277 | — | plan? |
| Feb 7, 2019 FMForm 4 → | Feb 11, 7:48 pm EST | Edward T DodsonPrincipal Accounting Officer | 315 | $147.46 | $10,027 | 9,444 | — | plan? |
| Feb 7, 2019 FMForm 4 → | Feb 11, 7:46 pm EST | Lisa J UthgenanntChief Human Resources Officer | 475 | $147.46 | $21,824 | 3,972 | — | plan? |
| Feb 7, 2019 FMForm 4 → | Feb 11, 7:44 pm EST | Lance BerberianSVP, Chief Information Officer | 401 | $147.46 | $15,336 | 6,133 | — | plan? |
| Nov 27, 2018 SForm 4 → | Nov 29, 10:00 am EST | R Sanders WilliamsDirector | 350 | $162.14 | $56,749 | 7,886 | −4.25% | plan? |
| Nov 19, 2018 GMForm 4 → | Feb 14, 2019, 4:24 pm EST | Adam H SchechterDirector | 1,648 | — | — | 6,462 | — | plan? late |
| Nov 5, 2018 SForm 4 → | Nov 7, 10:54 am EST | Kerrii B AndersonDirector | 3,700 | $163.29 | $604,162 | 18,095 | −17.0% | plan? |
| Nov 5, 2018 MForm 4 → | Nov 7, 10:54 am EST | Kerrii B AndersonDirector | 3,700 | $64.42 | $238,354 | 21,795 | — | plan? |
| Sep 4, 2018 FMForm 4 → | Sep 6, 10:21 am EDT | M. Huff GaryCEO, LabCorp Diagnostics | 222 | $169.15 | $11,671 | 1,850 | — | plan? |
| Aug 13, 2018 GForm 4 → | Aug 15, 5:41 pm EDT | David P KingPresident & CEO, Director | 2,084 | — | — | 219,711 | — | plan? |
| Jun 6, 2018 SForm 4 → | Jun 8, 11:11 am EDT | Edward T DodsonPrincipal Accounting Officer | 13,000 | $183.35 | $2,383,558 | 9,113 | −58.8% | plan? |
| Jun 6, 2018 MForm 4 → | Jun 8, 11:11 am EDT | Edward T DodsonPrincipal Accounting Officer | 13,000 | $84.86 | $1,103,180 | 22,113 | — | plan? |
| Jun 4, 2018 SForm 4 → | Jun 6, 2:59 pm EDT | Lisa J UthgenanntChief Human Resources Officer | 4,500 | $182.10 | $819,451 | 3,755 | −54.5% | plan? |
| May 31, 2018 SForm 4 → | Jun 4, 4:17 pm EDT | Dwight Gary GillilandDirector | 1,263 | $181.29 | $228,967 | 3,501 | −26.5% | plan? |
| May 31, 2018 SForm 4 → | Jun 4, 4:16 pm EDT | Lance BerberianSVP, Chief Information Officer | 5,500 | $182.30 | $1,002,672 | 5,940 | −48.1% | plan? |
| May 30, 2018 SForm 4 → | Jun 1, 8:15 am EDT | M. Huff GaryCEO, LabCorp Diagnostics | 1,610 | $182.50 | $293,823 | 1,610 | −50.0% | plan? |
| May 30, 2018 SForm 4 → | Jun 1, 8:14 am EDT | Glenn A EisenbergChief Financial Officer, EVP | 10,000 | $181.21 | $1,812,065 | 15,563 | −39.1% | plan? |
| May 23, 2018 SForm 4 → | May 25, 11:15 am EDT | David P KingPresident & CEO, Director | 49,966 | $175.37 | $8,762,344 | 221,669 | −18.4% | plan? |
| May 23, 2018 MForm 4 → | May 25, 11:15 am EDT | David P KingPresident & CEO, Director | 49,966 | $84.86 | $4,240,115 | 271,635 | — | plan? |
| Apr 23, 2018 SForm 4 → | Apr 25, 4:59 pm EDT | David P KingPresident & CEO, Director | 49,967 | $166.12 | $8,300,696 | 221,669 | −18.4% | plan? |
| Apr 23, 2018 MForm 4 → | Apr 25, 4:59 pm EDT | David P KingPresident & CEO, Director | 49,967 | $84.86 | $4,240,200 | 271,636 | — | plan? |
| Apr 4, 2018 FMForm 4 → | Apr 6, 9:39 am EDT | M. Huff GaryCEO, LabCorp Diagnostics | 4,876 | $163.84 | $225,444 | 3,220 | — | plan? |
| Mar 29, 2018 AFForm 4 → | Apr 2, 11:54 am EDT | Lance BerberianSVP, Chief Information Officer | 6,973 | $161.75 | $343,072 | 11,440 | — | plan? |
| Mar 29, 2018 AFForm 4 → | Apr 2, 11:53 am EDT | Edward T DodsonPrincipal Accounting Officer | 6,452 | $161.75 | $258,800 | 9,113 | — | plan? |
| Mar 29, 2018 AFForm 4 → | Apr 2, 11:51 am EDT | F Samuel Eberts IIIChief Legal Officer, Secretary | 7,747 | $161.75 | $348,086 | 28,062 | — | plan? |
| Mar 29, 2018 AFForm 4 → | Apr 2, 11:50 am EDT | Glenn A EisenbergChief Financial Officer, EVP | 28,537 | $161.75 | $1,431,488 | 25,563 | — | plan? |
| Mar 29, 2018 AFForm 4 → | Apr 2, 11:48 am EDT | David P KingPresident & CEO, Director | 106,464 | $161.75 | $5,340,176 | 221,669 | — | plan? |
| Mar 29, 2018 AFForm 4 → | Apr 2, 11:47 am EDT | Lisa J UthgenanntChief Human Resources Officer | 9,321 | $161.75 | $457,429 | 8,255 | — | plan? |
| Mar 23, 2018 SForm 4 → | Mar 27, 9:03 am EDT | David P KingPresident & CEO, Director | 49,967 | $164.75 | $8,232,218 | 181,235 | −21.6% | plan? |
| Mar 23, 2018 MForm 4 → | Mar 27, 9:03 am EDT | David P KingPresident & CEO, Director | 49,967 | $84.86 | $4,240,200 | 231,202 | — | plan? |
| Mar 12, 2018 FMForm 4 → | Mar 14, 4:12 pm EDT | Edward T DodsonPrincipal Accounting Officer | 511 | $175.61 | $19,493 | 5,861 | — | plan? |
| Mar 12, 2018 FMForm 4 → | Mar 14, 3:47 pm EDT | David P KingPresident & CEO, Director | 8,809 | $175.61 | $479,767 | 181,235 | — | plan? |
| Mar 12, 2018 FMForm 4 → | Mar 14, 3:38 pm EDT | F Samuel Eberts IIIChief Legal Officer, Secretary | 593 | $175.61 | $22,654 | 24,619 | — | plan? |
| Mar 12, 2018 FMForm 4 → | Mar 14, 3:33 pm EDT | Glenn A EisenbergChief Financial Officer, EVP | 2,359 | $175.61 | $128,547 | 14,726 | — | plan? |
| Mar 12, 2018 FMForm 4 → | Mar 14, 3:30 pm EDT | Lance BerberianSVP, Chief Information Officer | 520 | $175.61 | $21,073 | 8,709 | — | plan? |
| Mar 12, 2018 FMForm 4 → | Mar 14, 3:28 pm EDT | Lisa J UthgenanntChief Human Resources Officer | 721 | $175.61 | $32,312 | 4,590 | — | plan? |
| Feb 12, 2018 SForm 4 → | Feb 14, 2:32 pm EST | Glenn A EisenbergChief Financial Officer, EVP | 8,400 | $167.36 | $1,405,840 | 13,831 | −37.8% | plan? |
| Feb 9, 2018 FMForm 4 → | Feb 13, 2:08 pm EST | John D RatliffCEO, Covance Drug Development | 8,232 | $168.08 | $358,347 | 9,398 | — | plan? |
| Feb 9, 2018 SForm 4 → | Feb 13, 1:58 pm EST | Kerrii B AndersonDirector | 3,300 | $166.10 | $548,124 | 18,095 | −15.4% | plan? |
| Feb 9, 2018 MForm 4 → | Feb 13, 1:58 pm EST | Kerrii B AndersonDirector | 3,300 | $75.63 | $249,579 | 21,395 | — | plan? |
| Feb 9, 2018 FMForm 4 → | Feb 13, 1:55 pm EST | Glenn A EisenbergChief Financial Officer, EVP | 6,339 | $168.08 | $245,733 | 22,231 | — | plan? |
| Feb 9, 2018 FMForm 4 → | Feb 13, 1:54 pm EST | Lance BerberianSVP, Chief Information Officer | 4,545 | $168.08 | $176,148 | 8,429 | — | plan? |
| Feb 9, 2018 FMForm 4 → | Feb 13, 1:51 pm EST | Edward T DodsonPrincipal Accounting Officer | 617 | $168.08 | $28,069 | 5,506 | — | plan? |
| Feb 9, 2018 FMForm 4 → | Feb 13, 1:47 pm EST | F Samuel Eberts IIIChief Legal Officer, Secretary | 664 | $168.08 | $24,204 | 24,284 | — | plan? |
| Feb 9, 2018 FMForm 4 → | Feb 13, 1:46 pm EST | Lisa J UthgenanntChief Human Resources Officer | 806 | $168.08 | $34,120 | 4,237 | — | plan? |
| Feb 9, 2018 FMForm 4 → | Feb 13, 1:44 pm EST | David P KingPresident & CEO, Director | 10,681 | $168.08 | $527,435 | 177,890 | — | plan? |
| Feb 8, 2018 SForm 4 → | Feb 9, 3:56 pm EST | Adam H SchechterDirector | 1,263 | $169.29 | $213,813 | 6,034 | −17.3% | plan? |
| Feb 7, 2018 FMForm 4 → | Feb 9, 4:16 pm EST | Lisa J UthgenanntChief Human Resources Officer | 455 | $169.66 | $21,886 | 3,837 | — | plan? |
| Feb 7, 2018 FMForm 4 → | Feb 9, 4:13 pm EST | David P KingPresident & CEO, Director | 5,484 | $169.66 | $214,450 | 173,485 | — | plan? |
| Feb 7, 2018 FMForm 4 → | Feb 9, 4:11 pm EST | John D RatliffCEO, Covance Drug Development | 2,423 | $169.66 | $95,010 | 5,430 | — | plan? |
| Feb 7, 2018 FMForm 4 → | Feb 9, 4:09 pm EST | M. Huff GaryCEO, LabCorp Diagnostics | 1,405 | $169.66 | $55,818 | 1,096 | — | plan? |
| Feb 7, 2018 FMForm 4 → | Feb 9, 4:05 pm EST | Glenn A EisenbergChief Financial Officer, EVP | 1,292 | $169.66 | $50,728 | 18,816 | — | plan? |
| Feb 7, 2018 FMForm 4 → | Feb 9, 4:02 pm EST | F Samuel Eberts IIIChief Legal Officer, Secretary | 378 | $169.66 | $13,912 | 23,908 | — | plan? |
| Feb 7, 2018 FMForm 4 → | Feb 9, 4:01 pm EST | Edward T DodsonPrincipal Accounting Officer | 338 | $169.66 | $15,609 | 5,223 | — | plan? |
| Feb 7, 2018 FMForm 4 → | Feb 9, 3:59 pm EST | Lance BerberianSVP, Chief Information Officer | 401 | $169.66 | $17,814 | 5,980 | — | plan? |
| Feb 7, 2018 MForm 4 → | Feb 9, 3:57 pm EST | R Sanders WilliamsDirector | 1,263 | — | — | 8,236 | — | plan? |
| Feb 7, 2018 MForm 4 → | Feb 9, 3:56 pm EST | Adam H SchechterDirector | 1,263 | — | — | 7,297 | — | plan? |
| Feb 7, 2018 MForm 4 → | Feb 9, 3:54 pm EST | Richelle P ParhamDirector | 1,263 | — | — | 2,823 | — | plan? |
| Feb 7, 2018 MForm 4 → | Feb 9, 3:53 pm EST | Peter M NeupertDirector | 1,263 | — | — | 7,731 | — | plan? |
| Feb 7, 2018 MForm 4 → | Feb 9, 3:52 pm EST | Robert E Mittelstaedt Jr.Director | 1,263 | — | — | 14,171 | — | plan? |
| Feb 7, 2018 MForm 4 → | Feb 9, 3:50 pm EST | Garheng KongDirector | 1,263 | — | — | 6,187 | — | plan? |
| Feb 7, 2018 MForm 4 → | Feb 9, 3:49 pm EST | Dwight Gary GillilandDirector | 1,263 | — | — | 4,764 | — | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 1, 2026 AForm 4 → | Sep 3, 8:21 am EDT | Akinbolade OyegunwaEVP, CIO & CTO | 750 | — | — | 2,940 | — | |
| Sep 1, 2026 AForm 4 → | Sep 3, 8:19 am EDT | Jonathan C MeltzerEVP, COO | 900 | — | — | 3,594 | — | |
| Sep 1, 2026 AForm 4 → | Sep 3, 8:18 am EDT | Bryan T VaughnEVP and President, Diagnostics | 1,500 | — | — | 5,204 | — | |
| Sep 1, 2026 AForm 4 → | Sep 3, 8:07 am EDT | Brian J CaveneyEVP, Pres of BLS, CMO & CSO | 3,000 | — | — | 7,170 | — | |
| Aug 3, 2026 MForm 4 → | Aug 5, 11:17 am EDT | Peter J WilkinsonSVP, Chief Accounting Officer | 1,338 | — | — | 0 | — | |
| Jul 1, 2026 MForm 4 → | Jul 6, 9:37 am EDT | Kathryn W KyleEVP, Chief Legal Officer | 256 | — | — | 2,008 | — | 10b5-1 |
| Jul 1, 2026 MForm 4 → | Jul 6, 9:36 am EDT | Bryan T VaughnEVP and President, Diagnostics | 327 | — | — | 3,704 | — | 10b5-1 |
| Feb 12, 2019 AMForm 4 → | Feb 14, 5:01 pm EST | Jean-Luc BelingardDirector | 5,965 | — | — | 4,506 | — | |
| Feb 12, 2019 AMForm 4 → | Feb 14, 4:44 pm EST | David P KingPresident & CEO, Director | 68,523 | — | — | 52,300 | — | |
| Feb 12, 2019 AMForm 4 → | Feb 14, 4:37 pm EST | Peter M NeupertDirector | 2,265 | — | — | 1,227 | — | |
| Feb 12, 2019 AMForm 4 → | Feb 14, 4:33 pm EST | Dwight Gary GillilandDirector | 2,265 | — | — | 1,227 | — | |
| Feb 12, 2019 AMForm 4 → | Feb 14, 4:30 pm EST | Kerrii B AndersonDirector | 2,265 | — | — | 1,227 | — | |
| Feb 12, 2019 AMForm 4 → | Feb 14, 4:27 pm EST | Garheng KongDirector | 2,265 | — | — | 1,227 | — | |
| Feb 12, 2019 AMForm 4 → | Feb 14, 4:26 pm EST | Richelle P ParhamDirector | 2,265 | — | — | 1,227 | — | |
| Feb 12, 2019 AMForm 4 → | Feb 14, 4:25 pm EST | Robert E Mittelstaedt Jr.Director | 1,344 | — | — | 306 | — | |
| Feb 12, 2019 AMForm 4 → | Feb 14, 4:24 pm EST | Adam H SchechterDirector | 2,265 | — | — | 1,227 | — | |
| Feb 12, 2019 AMForm 4 → | Feb 14, 4:18 pm EST | R Sanders WilliamsDirector | 2,265 | — | — | 1,227 | — | |
| Feb 12, 2019 MForm 4 → | Feb 14, 4:13 pm EST | Edward T DodsonPrincipal Accounting Officer | 196 | — | — | 641 | — | |
| Feb 12, 2019 MForm 4 → | Feb 14, 4:10 pm EST | F Samuel Eberts IIIChief Legal Officer, Secretary | 233 | — | — | 764 | — | |
| Feb 12, 2019 AMForm 4 → | Feb 14, 4:08 pm EST | John D RatliffCEO, Covance Drug Development | 28,563 | — | — | 21,800 | — | |
| Feb 12, 2019 AMForm 4 → | Feb 14, 4:05 pm EST | Glenn A EisenbergChief Financial Officer, EVP | 15,200 | — | — | 11,600 | — | |
| Feb 12, 2019 AMForm 4 → | Feb 14, 4:02 pm EST | Lance BerberianSVP, Chief Information Officer | 12,753 | — | — | 4,400 | — | |
| Feb 12, 2019 AMForm 4 → | Feb 14, 3:59 pm EST | Brian J CaveneySVP, Chief Medical Officer | 11,643 | — | — | 3,500 | — | |
| Feb 12, 2019 AMForm 4 → | Feb 14, 3:58 pm EST | Lisa J UthgenanntChief Human Resources Officer | 4,986 | — | — | 3,800 | — | |
| Feb 11, 2019 MForm 4 → | Feb 13, 12:22 pm EST | Lisa J UthgenanntChief Human Resources Officer | 604 | — | — | 1,097 | — | |
| Feb 11, 2019 MForm 4 → | Feb 13, 12:18 pm EST | Edward T DodsonPrincipal Accounting Officer | 450 | — | — | 837 | — | |
| Feb 11, 2019 MForm 4 → | Feb 13, 12:11 pm EST | David P KingPresident & CEO, Director | 7,544 | — | — | 14,760 | — | |
| Feb 11, 2019 MForm 4 → | Feb 13, 12:09 pm EST | F Samuel Eberts IIIChief Legal Officer, Secretary | 520 | — | — | 997 | — | |
| Feb 11, 2019 MForm 4 → | Feb 13, 12:05 pm EST | Glenn A EisenbergChief Financial Officer, EVP | 4,877 | — | — | 3,334 | — | |
| Feb 11, 2019 MForm 4 → | Feb 13, 12:00 pm EST | Lance BerberianSVP, Chief Information Officer | 3,497 | — | — | 997 | — | |
| Feb 11, 2019 MForm 4 → | Feb 13, 11:55 am EST | John D RatliffCEO, Covance Drug Development | 6,100 | — | — | 18,374 | — | |
| Feb 7, 2019 MForm 4 → | Feb 11, 7:59 pm EST | John D RatliffCEO, Covance Drug Development | 1,863 | — | — | 24,474 | — | |
| Feb 7, 2019 MForm 4 → | Feb 11, 7:56 pm EST | David P KingPresident & CEO, Director | 4,220 | — | — | 22,304 | — | |
| Feb 7, 2019 MForm 4 → | Feb 11, 7:53 pm EST | Glenn A EisenbergChief Financial Officer, EVP | 993 | — | — | 8,211 | — | |
| Feb 7, 2019 MForm 4 → | Feb 11, 7:51 pm EST | F Samuel Eberts IIIChief Legal Officer, Secretary | 297 | — | — | 1,517 | — | |
| Feb 7, 2019 MForm 4 → | Feb 11, 7:48 pm EST | Edward T DodsonPrincipal Accounting Officer | 247 | — | — | 1,287 | — | |
| Feb 7, 2019 MForm 4 → | Feb 11, 7:46 pm EST | Lisa J UthgenanntChief Human Resources Officer | 327 | — | — | 1,701 | — | |
| Feb 7, 2019 MForm 4 → | Feb 11, 7:44 pm EST | Lance BerberianSVP, Chief Information Officer | 297 | — | — | 4,494 | — | |
| Dec 4, 2018 AForm 4 → | Dec 7, 4:17 pm EST | Jean-Luc BelingardDirector | 3,174 | — | — | 4,212 | — | |
| Nov 5, 2018 MForm 4 → | Nov 7, 10:54 am EST | Kerrii B AndersonDirector | 3,700 | — | — | 0 | — | |
| Sep 4, 2018 MForm 4 → | Sep 6, 10:21 am EDT | M. Huff GaryCEO, LabCorp Diagnostics | 153 | — | — | 11,068 | — | |
| Jun 6, 2018 MForm 4 → | Jun 8, 11:11 am EDT | Edward T DodsonPrincipal Accounting Officer | 13,000 | — | — | 0 | — | |
| May 23, 2018 MForm 4 → | May 25, 11:15 am EDT | David P KingPresident & CEO, Director | 49,966 | — | — | 0 | — | |
| Apr 23, 2018 MForm 4 → | Apr 25, 4:59 pm EDT | David P KingPresident & CEO, Director | 49,967 | — | — | 49,966 | — | |
| Apr 4, 2018 MForm 4 → | Apr 6, 9:39 am EDT | M. Huff GaryCEO, LabCorp Diagnostics | 3,500 | — | — | 11,221 | — | |
| Apr 3, 2018 AForm 4 → | Apr 5, 10:14 am EDT | John D RatliffCEO, Covance Drug Development | 12,120 | — | — | 26,337 | — | |
| Mar 23, 2018 MForm 4 → | Mar 27, 9:03 am EDT | David P KingPresident & CEO, Director | 49,967 | — | — | 99,933 | — | |
| Mar 12, 2018 MForm 4 → | Mar 14, 4:12 pm EDT | Edward T DodsonPrincipal Accounting Officer | 400 | — | — | 1,534 | — | |
| Mar 12, 2018 MForm 4 → | Mar 14, 3:47 pm EDT | David P KingPresident & CEO, Director | 6,077 | — | — | 26,524 | — | |
| Mar 12, 2018 MForm 4 → | Mar 14, 3:38 pm EDT | F Samuel Eberts IIIChief Legal Officer, Secretary | 464 | — | — | 1,814 | — | |
| Mar 12, 2018 MForm 4 → | Mar 14, 3:33 pm EDT | Glenn A EisenbergChief Financial Officer, EVP | 1,627 | — | — | 9,204 | — | |
| Mar 12, 2018 MForm 4 → | Mar 14, 3:30 pm EDT | Lance BerberianSVP, Chief Information Officer | 400 | — | — | 4,791 | — | |
| Mar 12, 2018 MForm 4 → | Mar 14, 3:28 pm EDT | Lisa J UthgenanntChief Human Resources Officer | 537 | — | — | 2,028 | — | |
| Feb 12, 2018 AForm 4 → | Feb 14, 2:34 pm EST | David P KingPresident & CEO, Director | 51,540 | — | — | 41,000 | — | |
| Feb 12, 2018 AForm 4 → | Feb 14, 2:32 pm EST | Glenn A EisenbergChief Financial Officer, EVP | 11,440 | — | — | 10,831 | — | |
| Feb 12, 2018 AForm 4 → | Feb 14, 2:31 pm EST | Brian J CaveneySVP, Chief Medical Officer | 3,400 | — | — | 1,670 | — | |
| Feb 12, 2018 AForm 4 → | Feb 14, 2:28 pm EST | F Samuel Eberts IIIChief Legal Officer, Secretary | 3,400 | — | — | 2,278 | — | |
| Feb 12, 2018 AForm 4 → | Feb 14, 2:27 pm EST | Lisa J UthgenanntChief Human Resources Officer | 3,770 | — | — | 2,565 | — | |
| Feb 12, 2018 AForm 4 → | Feb 14, 2:25 pm EST | John D RatliffCEO, Covance Drug Development | 21,490 | — | — | 14,217 | — | |
| Feb 12, 2018 AForm 4 → | Feb 14, 2:24 pm EST | Edward T DodsonPrincipal Accounting Officer | 2,890 | — | — | 1,934 | — | |
| Feb 12, 2018 AForm 4 → | Feb 14, 2:23 pm EST | Lance BerberianSVP, Chief Information Officer | 3,400 | — | — | 5,191 | — | |
| Feb 12, 2018 AForm 4 → | Feb 14, 2:21 pm EST | M. Huff GaryCEO, LabCorp Diagnostics | 8,560 | — | — | 14,721 | — | |
| Feb 12, 2018 AForm 4 → | Feb 14, 9:15 am EST | R Sanders WilliamsDirector | 1,038 | — | — | 1,038 | — | |
| Feb 12, 2018 AForm 4 → | Feb 14, 9:14 am EST | Adam H SchechterDirector | 1,038 | — | — | 1,038 | — | |
| Feb 12, 2018 AForm 4 → | Feb 14, 9:12 am EST | Richelle P ParhamDirector | 1,038 | — | — | 1,038 | — | |
| Feb 12, 2018 AForm 4 → | Feb 14, 9:11 am EST | Peter M NeupertDirector | 1,038 | — | — | 1,038 | — | |
| Feb 12, 2018 AForm 4 → | Feb 14, 9:09 am EST | Robert E Mittelstaedt Jr.Director | 1,038 | — | — | 1,038 | — | |
| Feb 12, 2018 AForm 4 → | Feb 14, 9:08 am EST | Garheng KongDirector | 1,038 | — | — | 1,038 | — | |
| Feb 12, 2018 AForm 4 → | Feb 14, 9:07 am EST | Dwight Gary GillilandDirector | 1,038 | — | — | 1,038 | — | |
| Feb 12, 2018 AForm 4 → | Feb 14, 9:05 am EST | Jean-Luc BelingardDirector | 1,038 | — | — | 1,038 | — | |
| Feb 12, 2018 AForm 4 → | Feb 14, 9:04 am EST | Kerrii B AndersonDirector | 1,038 | — | — | 1,038 | — | |
| Feb 9, 2018 MForm 4 → | Feb 13, 2:08 pm EST | John D RatliffCEO, Covance Drug Development | 6,100 | — | — | 9,827 | — | |
| Feb 9, 2018 MForm 4 → | Feb 13, 1:58 pm EST | Kerrii B AndersonDirector | 3,300 | — | — | 0 | — | |
| Feb 9, 2018 MForm 4 → | Feb 13, 1:55 pm EST | Glenn A EisenbergChief Financial Officer, EVP | 4,877 | — | — | 8,491 | — | |
| Feb 9, 2018 MForm 4 → | Feb 13, 1:54 pm EST | Lance BerberianSVP, Chief Information Officer | 3,497 | — | — | 4,491 | — | |
| Feb 9, 2018 MForm 4 → | Feb 13, 1:51 pm EST | Edward T DodsonPrincipal Accounting Officer | 450 | — | — | 1,344 | — | |
| Feb 9, 2018 MForm 4 → | Feb 13, 1:47 pm EST | F Samuel Eberts IIIChief Legal Officer, Secretary | 520 | — | — | 1,578 | — | |
| Feb 9, 2018 MForm 4 → | Feb 13, 1:46 pm EST | Lisa J UthgenanntChief Human Resources Officer | 603 | — | — | 1,795 | — | |
| Feb 9, 2018 MForm 4 → | Feb 13, 1:44 pm EST | David P KingPresident & CEO, Director | 7,543 | — | — | 22,061 | — | |
| Feb 7, 2018 MForm 4 → | Feb 9, 4:16 pm EST | Lisa J UthgenanntChief Human Resources Officer | 326 | — | — | 2,398 | — | |
| Feb 7, 2018 MForm 4 → | Feb 9, 4:13 pm EST | David P KingPresident & CEO, Director | 4,220 | — | — | 29,604 | — | |
| Feb 7, 2018 MForm 4 → | Feb 9, 4:11 pm EST | John D RatliffCEO, Covance Drug Development | 1,863 | — | — | 15,927 | — | |
| Feb 7, 2018 MForm 4 → | Feb 9, 4:09 pm EST | M. Huff GaryCEO, LabCorp Diagnostics | 1,076 | — | — | 12,961 | — | |
| Feb 7, 2018 MForm 4 → | Feb 9, 4:05 pm EST | Glenn A EisenbergChief Financial Officer, EVP | 993 | — | — | 13,368 | — | |
| Feb 7, 2018 MForm 4 → | Feb 9, 4:02 pm EST | F Samuel Eberts IIIChief Legal Officer, Secretary | 296 | — | — | 2,098 | — | |
| Feb 7, 2018 MForm 4 → | Feb 9, 4:01 pm EST | Edward T DodsonPrincipal Accounting Officer | 246 | — | — | 1,794 | — | |
| Feb 7, 2018 MForm 4 → | Feb 9, 3:59 pm EST | Lance BerberianSVP, Chief Information Officer | 296 | — | — | 7,988 | — | |
| Feb 7, 2018 MForm 4 → | Feb 9, 3:57 pm EST | R Sanders WilliamsDirector | 1,263 | — | — | 0 | — | |
| Feb 7, 2018 MForm 4 → | Feb 9, 3:56 pm EST | Adam H SchechterDirector | 1,263 | — | — | 0 | — | |
| Feb 7, 2018 MForm 4 → | Feb 9, 3:54 pm EST | Richelle P ParhamDirector | 1,263 | — | — | 0 | — | |
| Feb 7, 2018 MForm 4 → | Feb 9, 3:53 pm EST | Peter M NeupertDirector | 1,263 | — | — | 0 | — | |
| Feb 7, 2018 MForm 4 → | Feb 9, 3:52 pm EST | Robert E Mittelstaedt Jr.Director | 1,263 | — | — | 0 | — | |
| Feb 7, 2018 MForm 4 → | Feb 9, 3:50 pm EST | Garheng KongDirector | 1,263 | — | — | 0 | — | |
| Feb 7, 2018 MForm 4 → | Feb 9, 3:49 pm EST | Dwight Gary GillilandDirector | 1,263 | — | — | 0 | — | |
| Feb 7, 2018 MForm 4 → | Feb 9, 3:47 pm EST | Jean-Luc BelingardDirector | 1,263 | — | — | 0 | — | |
| Feb 7, 2018 MForm 4 → | Feb 9, 3:44 pm EST | Kerrii B AndersonDirector | 1,263 | — | — | 0 | — | |
| Sep 25, 2017 AForm 4 → | Sep 27, 11:18 am EDT | Brian J CaveneySVP, Chief Medical Officer | 970 | — | — | 970 | — | |
| Sep 6, 2017 MForm 4 → | Sep 7, 3:35 pm EDT | David P KingPresident & CEO, Director | 44,687 | — | — | 0 | — | |
| Sep 5, 2017 MForm 4 → | Sep 7, 9:18 am EDT | David P KingPresident & CEO, Director | 132,713 | — | — | 44,687 | — | |
| Sep 1, 2017 MForm 4 → | Oct 23, 4:10 pm EDT | M. Huff GaryCEO, LabCorp Diagnostics | 153 | — | — | 14,037 | — | late |
Filed by this entity as an insider elsewhere — common stock
| Trade | Reported (ET) | Company | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 7, 2016 PForm 4 → | Sep 7, 5:22 pm EDT | SEQUENOM INCSQNM | 36,649,440 | $2.40 | $87,958,656 | 119,551,297 | +44.2% | plan? |
Filed by this entity as an insider elsewhere — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.